Elia Group SA/NV (EBR:ELI)

Revance Therapeutics Revenue

Elia Group had revenue of 2.17B EUR in the half year ending June 30, 2025, with 3.66% growth. This brings the company's revenue in the last twelve months to 4.15B, up 17.50% year-over-year. In the year 2024, Elia Group had annual revenue of 3.77B, down -1.97%.

• Revenue (ttm): 4.15B
• Revenue Growth: +17.50%
• P/S Ratio: 2.64
• Revenue / Employee: 1.03M
• Employees: 4,020
• Market Cap: 10.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.77B	-75.60M	-1.97%
Dec 31, 2023	3.84B	226.60M	6.27%
Dec 31, 2022	3.62B	1.06B	41.73%
Dec 31, 2021	2.55B	341.70M	15.46%
Dec 31, 2020	2.21B	-32.70M	-1.46%